Clinical Study
Hematopoietic Stem-Cell Transplantation in the Developing World: Experience from a Center in Western India
Table 3
Graft versus host disease prophylaxis.
| | Day | Prophylaxis regimen |
| | −1 | Cyclosporine 2.5 mg/kg/dose twice daily |
| | 0 | Peripheral stem-cell transplant |
| | 0 | Cyclosporine 1.5 mg/kg/dose twice daily; continued till day +90 and then gradually taper the dose |
| | +1, +3, +6, +11 | Methotrexate 15 mg/m2 on D +1, 10 mg/m2 on rest of days [6] |
| | +2, +4, +7, +12 | Two doses of leucovorin 15 mg/kg/every six hours starting 24 hours after methotrexate |
|
|
